Clinicians frequently must face questions from patients or family members about how long a terminally ill patient has to live. Even for the experienced clinician, end-of-life (EOL) estimates are a ...

Despite proven benefits for patients and value for health systems, access to palliative care remains limited due to lack of awareness and workforce shortages. Low reimbursement rates have made matters ...

Uncertainty of prognosis is one reason patients with hematologic malignancies receive aggressive therapy near end of life more often than those with advanced solid tumors. It is unknown whether end-of ...

Randomized, Double-Blind Trial on the Impact of Word Count in Cancer Clinical Trial Consent Forms We conducted a retrospective study of self-reported symptoms on the Edmonton Symptom Assessment System ...